Open Access

Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children

  • Authors:
    • Xinxian Zhang
    • Chenglong Li
    • Chao Xu
    • Xiangdong Hao
    • Xiao Yu
    • Qiancheng Li
  • View Affiliations

  • Published online on: June 12, 2018     https://doi.org/10.3892/ol.2018.8959
  • Pages: 2439-2443
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Correlation between computed tomography (CT) signs, lymphatic metastasis and pathological features of neuroblastoma (NB) in children was investigated. A total of 374 child patients diagnosed with NB via CT scan and pathological section in Department of Pediatric of Xuzhou Children's Hospital from March 2011 to January 2017 were collected, and their clinical data were retrospectively analyzed. According to CT signs, NB calcification and invasion to surrounding tissues were evaluated, and the tumor site, tumor size, lymphatic metastasis, pathological types and clinical prognosis were analyzed. In plain CT scan, 160 cases showed clear tumor mass, and 214 cases showed blurred mass; 78 cases of tumors were uniform in density, and 296 cases were not uniform in density. Besides, there were 351 cases of calcification in mass. There were 106 cases of axial rotation of kidney, 53 cases of enlargement of renal calyce and renal pelvis, 66 cases of elevation of liver position, 71 cases of pancreas translocation, 26 cases of gastrointestinal tract translocation, 17 cases of vascular translocation and 12 cases of bladder translocation, besides 23 of the cases showed no significantly abnormal changes. Moreover, 211 cases had retroperitoneal lymphatic metastasis with soft tissue swelling in phrenic angle, abdominal aorta and renal hilum in image, and non-uniform annular enhancement or uniform enhancement in enhanced scanning. NB in right adrenal gland invaded the liver in 53 cases, invaded the kidney in 26 cases, invaded the psoas in 40 cases and blood vessels in 32 cases, and the remaining cases showed no invasion. A total of 68 cases were accompanied by pleural thickening, 34 cases by pleural effusion, 36 cases by tracheal compression, 38 cases by rib compression, and 40 cases by tumor invading into vertebral canal. Bone metastasis occurred in 182 cases; liver metastases occurred in 28 cases, and brain metastases in 35 cases. NB calcification was significantly correlated with pathological type, tumor site and lymphatic metastasis (p<0.05), but not correlated with tumor size (p>0.05); NB invasion to surrounding tissues was associated with pathological type, tumor site and clinical prognosis (p<0.05), but was not correlated with the tumor size (p>0.05). We concluded that patients with distal mediastinal mass identified by CT examination, accompanied by calcification, and invasion to surrounding tissues may suffer from NB. Tumor growth is closely correlated with tumor differentiation degree.

Introduction

Neuroblastoma (NB) is a common malignancy in children aged below 8 years, and its incidence is about 1/80,000 worldwide, which is only lower than that of nephroblastoma (1). NB mainly occurs in the retroperitoneal, postmediastinal, inferior cervical, posterior pelvic wall and adrenal medullary sympathetic nervous system, among which retroperitoneal NB as the most common type accounts for about 70% of all cases (2). Treatment outcomes of retroperitoneal NB and its prognosis are usually poor compared with other types of NB (3). NB usually shows no obvious characteristics in early stage, and is indistinguishable from flu and fever, and is easily ignored, therefore, most patients are diagnosed at advanced stages (4). Shinagawa et al (5) reported that the mortality rate of stage-IV NB patients within 4 years is up to 65%. Surgery combined with drug therapy has been widely applied in the clinical treatment of NB, but radical treatments are lacking, so the diagnosis and treatment of NB now is a hot research topic worldwide (6). Diagnostic values of computed tomography (CT) for NB have been well studied (7,8), but the correlation between CT signs and pathological features of child patients with NB has not been reported. Therefore, in this study, CT signs of child patients with NB were retrospectively analyzed, and their correlation with pathological features of CT was explored with an expectation of providing reference and guidance for the clinical diagnosis and treatment of NB in the future.

Materials and methods

General data

A total of 374 child patients diagnosed with NB via CT scan and pathological examination in Department of Pediatric of Xuzhou Children's Hospital from March 2011 to January 2017 were collected, and their clinical data were retrospectively analyzed. Those patients included 216 males and 158 females, and the age ranged from 4 months to 8 years with a median age of 3.6 years.

Inclusion and exclusion criteria

Inclusion criteria: Patients received CT scan during the treatment in Xuzhou Children's Hospital (Xuzhou, Jiangsu) and with complete imaging data; patients pathologically diagnosed with NB in the hospital; patients with complete medical records; patients strictly followed the instructions of the doctors during treatment. Exclusion criteria: Patients complicated with other cardiovascular and cerebrovascular diseases; patients complicated with digestive tract diseases; patients used antibiotics before admission; anemia patients. The family members of the patients signed informed consent. This study was approved by the Ethics Committee of Xuzhou Children's Hospital (Xuzhou, Jiangsu).

Methods

All child patients underwent continuous volume cranial scanning using Philips Brilliance 16-slice spiral CT scanner ((Philips, Amsterdam, Holland). CT parameter settings are shown in Table I. Plain and enhancement scans were performed from diaphragmatic dome to the pubic symphysis of child patients with iohexol as the contrast agent. Original image data were sent to the ADW4.5 Workstation for multi-planar reconstruction (MPR), volume rendering (VR) and curved planar reconstruction (CPR). Tumor tissue sections of patients were fixed in 10% formaldehyde, followed by paraffin embedding, and hematoxylin and eosin staining. Immunohistochemical staining was also performed using neuron-specific enolase (NES), S-100 protein (S-100), synaptophysin (Syn) and chromogranin A (CgA). According to CT signs, NB calcification and invasion to surrounding tissues were evaluated by microscope (Olympus, Tokyo, Japan), and the tumor site, tumor size, lymphatic metastasis, pathological type and clinical prognosis were analyzed.

Table I.

CT parameter setting.

Table I.

CT parameter setting.

Tube currentTube voltageLayer thicknessInterlayer spaceSpiral spaceReconstruction interval
130-190mA130-150kV3 mm1.5 mm1.11.5 mm

[i] CT, computed tomography.

Statistical analysis

Statistical Product and Service Solutions (IBM Corp., Armonk, NY, USA) 22.0 software was used for statistical analysis of data. Enumeration data were presented as rate, and processed using Chi-square test. Correlation analysis was performed using logistic regression analysis. P<0.05 was considered to indicate a statistically significant difference.

Results

Preliminary imaging results and clinical data of patients

According to the clinical data and preliminary imaging data of patients, incidence rate of child patients with a family disease history was higher than that of patients without a family disease history. No significant differences were found in sex, residence and delivery mode. The clinical symptoms were mainly irregular fever (87.4%), and abdominal mass and abdominal pain (79.1%). NB mainly originated from retroperitoneum (59.1%) and adrenal medulla (34.0%). The number of patients in the TNM stage III was the largest (49.2%) (Table II).

Table II.

Preliminary imaging results and clinical data of patients (N=374).

Table II.

Preliminary imaging results and clinical data of patients (N=374).

Parametersn (%)
Sex
  Male216 (57.8)
  Female158 (42.2)
Clinical manifestation
  Painless abdominal mass134 (35.8)
  Abdominal mass and abdominal pain296 (79.1)
  Chest tightness and cough251 (67.1)
  Frequent urination and urinary urgency87 (23.3)
  Bone joint pain52 (13.9)
  Irregular fever327 (87.4)
  Enlargement of superficial lymph nodes134 (35.8)
Tumor origin
  Adrenal medulla127 (34.0)
  Retroperitoneum221 (59.1)
  Sympathetic chain in pelvic cavity4 (1.1)
  Posterior mediastinum14 (3.7)
  Inferior neck8 (2.1)
Tumor lymph nodes metastasis (TNM)
  Stage I83 (22.2)
  Stage II107 (28.6)
  Stage III184 (49.2)
Place of residence
  Urban area206 (55.1)
  Rural area168 (44.9)
Delivery mode
  Eutocia172 (46.0)
  Cesarean202 (54.0)
Family medical history
  Yes295 (78.9)
  No79 (21.1)
Basic situations of tumor lesions

A total of 214 cases (57.2%) showed tumor lesions with blurred edge, and 160 cases (42.8%) showed clear edge. Size of lesion ranged from 2.0×4.0×4.0 cm to 12.0×14.0×15.0 cm. There were 178 cases (47.6%) with the lesion size >6.0×7.0×7.5 cm (median value), and 196 cases (52.4%) with the lesion size <6.0×7.0×7.5 cm. Lesions with irregular shape were found in 303 cases (81.0%), and lesions with oval or quasi-circular shape were found in 71 cases (19.0%) (Table III).

Table III.

Basic situations of tumor lesions (N=374).

Table III.

Basic situations of tumor lesions (N=374).

Parametersn (%)
Edge
  Blurred214 (57.2)
  Clear160 (42.8)
Size
  <6.0×7.0×7.5 cm178 (47.6)
  ≥6.0×7.0×7.5 cm196 (52.4)
Form
  Oval or quasi-circular shape71 (19.0)
  Irregular shape303 (81.0)
Tumor density

CT plain scan showed the non-uniform density of tumor in 296 cases, and cystic changes and necrosis in lesions in 219 cases. Tumor calcification occurred in 351 cases, and granular calcification was found in 196 cases (55.8%), and mass, flocky and patchy calcifications were found in other cases (Table IV). Enhanced scanning showed the non-uniform mild and moderate enhancement, and no enhancement was seen in regions with cystic changes and necrosis in lesions. Ninety four cases showed uniform low-density changes in lesions, 26 cases showed non-uniform mild and moderate enhancement, and 53 cases showed uniform mild enhancement.

Table IV.

Tumor calcification (N=351).

Table IV.

Tumor calcification (N=351).

Calcification formsn (%)
Granular196 (55.8)
Mass67 (19.1)
Flocky52 (14.8)
Patchy36 (10.3)
Space-occupying effect and outward invasion of tumor

The space-occupying effect of retroperitoneal mass was the most obvious, in which the kidney was pressed to move, and its anteroposterior diameter became smaller. In 374 patients, there were 106 cases of axial rotation of kidney, 53 cases of enlargement of renal calyce and renal pelvis, 66 cases of elevation of liver position, 71 cases of pancreas translocation, 26 cases of gastrointestinal tract translocation, 17 cases of vascular translocation and 12 cases of bladder translocation, while 23 cases showed no significantly abnormal changes. Moreover, 211 cases had retroperitoneal lymphatic metastasis with soft tissue swelling in phrenic angle, abdominal aorta and renal hilum in image, and non-uniform annular enhancement or uniform enhancement in enhanced scanning. NB in right adrenal gland invaded the liver in 53 cases, invaded kidney in 26 cases, invaded psoas in 40 cases and invaded blood vessels in 32 cases, and the remaining cases showed no invasion. Sixty eight cases were accompanied by pleural thickening, 34 cases by pleural effusion, 36 cases by tracheal compression, 38 cases by rib compression, and 40 cases by tumor invading into vertebral canal. Bone metastasis occurred in 182 cases, liver metastases in 28 cases and brain metastases in 35 cases.

Pathological section examination

Pathological examinations for 374 child patients showed that the tumor cells were mostly oval or quasi-circular in shape. Nuclei were deeply stained. The amount of cytoplasm was reduced, and cytoplasm was arranged like the petals of chrysanthemum. Bleeding, necrosis and calcium deposition were also observed. Marker Syn showed the highest positive rate (100%), followed by CgA (83.4%) (Table V).

Table V.

Marker detection.

Table V.

Marker detection.

MarkerPositive (n)Negative (n)Positive rate (%)
NES3027280.7
CgA3126283.4
S-10017120345.7
Syn3740100%
Correlation between CT signs and pathological features

Logistic regression analysis showed that tumor growth characteristics were closely correlated with the degree of differentiation and pathological changes (p<0.05), while no significant correlations with calcification were observed (p>0.05), (Table VI).

Table VI.

Logistic regression analysis of the correlation between CT signs and pathological features.

Table VI.

Logistic regression analysis of the correlation between CT signs and pathological features.

FeaturesPOR95% CI
Growth characteristics0.0221.591.07–2.37
Calcification0.0611.470.98–2.20
Degree of differentiation0.0171.641.09–2.47

[i] CT, computed tomography; OR, odds ratio; CI, confidence interval.

Discussion

NB, as a common type of malignant tumor, is mainly composed of neuroblasts. NB mainly originates from any neural crest in the sympathetic nervous system (9). In the clinical treatment of NB, targeted operation is often performed based on its risk factors, and the low-risk group only needs tumor resection, while the moderate-risk group requires peripheral organ repair after the removal of tumor tissues, and the high-risk group should receive stem cell transplantation; high-dose chemotherapy, and general radiotherapy after primary tumor tissues, and metastatic lesions are removed as much as possible (10). Due to the lack of typical symptoms in the early stage, NB can be easily ignored, and the optimal treatment timing may be missed. Besides, prognosis is different in patients with different types of NB, due to the heterogeneity of this disease (11). The treatment process of NB is complicated, and the postoperative survival rate is low, causing physical and mental harm and economic loss to patients and their families. In view of this, correlations between CT signs and pathological features of patients with NB were analyzed in this study, with an expectation of improving the early diagnosis and treatment of NB.

According to the case analysis, child patients with a family disease history had a higher incidence rate, suggesting that the family medical disease may be a risk factor of NB. Sex, residence and delivery mode showed no significant effects on the occurrence of NB. Almeida et al (12) reported that some genetic predisposing factors may be related to the pathogenesis of NB, and somatic mutations of lymphoma hormone may be one of the pathogeneses of familial NB. However, no previous study clarifies the pathogenesis of NB, so further study is needed. Clinical symptoms of NB mainly include irregular fever, abdominal distension and abdominal pain, which are related to the tumor site in patients. Retroperitoneal NB is the most common type, so the clinical manifestation is mostly abdominal mass (13). Krytska et al (14) showed that most parents of NB patients do not have sufficient medical knowledge, and the disease is usually ignored or misdiagnosed as abdominal distension and fever. Patients are often in TMN stage III, suggesting that parents should be educated with the clinical knowledge of early symptoms of NB to improve early diagnosis, and increase survival rate. Plain CT scan usually shows an irregular large soft tissue mass, unclear edge, no obvious capsule, more cells with less mesenchyme, high degree of malignancy, rapid development, proneness to cystic changes and necrosis in imaging of NB patients (15). In this study, 351 out of 374 cases showed calcification mainly with granular shape, but flocky and patchy calcification was also observed. The mass is large, and often extends across the midline to the opposite side to wrap the retroperitoneal large vessels. Metastasis occurs frequently in early stage of NB (16). In this study, there were 245 out of 374 cases of metastasis, among which there were 211 cases of retroperitoneal lymphatic metastasis. Therefore, the unexplained fever, abdominal distension, abdominal pain, chest tightness and cough in children may indicate existence of NB, and they should be treated as soon as possible once diagnosed. Besides, 174 showed invasion to the vertebral canal or liver. Enhancement scan showed non-uniform mild or moderate enhancement, but there was no enhancement in regions with cystic changes and necrotic area inside the lesions, which can be used as a criterion to determine the degree of tumor wrapped vessels and the integrity of kidney (17). For patients without cystic changes and necrosis, imaging results mostly showed less tumor cells with more mesenchyme and lower degree of malignancy. CT scan showed low density and clearer border, as well as mild or no enhancement in enhanced scanning, indicating that CT features are closely correlated with the tumor cell components. NB is a kind of malignant tumor with aggressive growth along the paravertebral sympathetic chain, and NB usually invaded or wrapped around the surrounding tissues or organs with spindle- or irregular-shapes (18). During development, NB can easily cross the midline, and invade the spinal canal along the neural tube, thus expanding the intervertebral foramen, and causing damage to the vertebral body (19). In this investigation 151 out of 374 patients with NB showed invasive growth, and CT showed the invasion to surrounding organs or tissues, and wrapped surrounding blood vessels was the main signs. There were 114 cases of NB showing limited mass compression and a low degree of malignancy in surrounding tissues, indicating that the tumor growth characteristics are closely correlated with the tumor differentiation degree. Grey white soft substances in tissue sections of patients with NB could be seen by the naked eye, and the microscopy showed round or quasi-circular shape with diffuse distribution or densely-arranged mass and unclear cell boundary. Moreover, there was less cytoplasm, uniform distribution of chromatin, petal-like arrangement, large and deeply-stained nuclei, prominent nucleoli, nuclear fission and fibrous trabecula in tumor mesenchyme. The positive rates of NES, CgA, S-100 and Syn in NB patients were 80.7%, 83.4%, 45.7% and 100%, respectively. NES, CgA, S-100 and Syn expression are observed in NB (20), and NES, CgA and Syn are neuroendocrine tumor markers with high specificity, so they can be used as important indicators to judge the severity of NB. The positive rates of markers were also basically consistent with the pathological stage and malignant degree of NB, indicating the promising application values of above markers in judging the severity of NB.

In conclusion, patients with distal mediastinal tumor identified via CT examination, accompanied by calcification, and invasion to surrounding tissues may suffer from NB, and the characteristics of tumor growth are closely correlated with tumor differentiation degree.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Authors' contributions

XZ, CL and CX were devoted to collecting and interpreting the data. XZ drafted this manuscript. XH and XY revised it critically for important intellectual content. XH, XY and QL were responsible for the conception and design of the study. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Xuzhou Children's Hospital (Xuzhou, Jiangsu). Signed informed consents were obtained from the guardians of the patients.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Irwin MS and Park JR: Neuroblastoma: Paradigm for precision medicine. Pediatr Clin North Am. 62:225–256. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, et al: Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 33:3008–3017. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, et al: Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature. 526:700–704. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Franscini LC, Vazquez-Montes M, Buclin T, Perera R, Dunand M, Grouzmann E and Beck-Popovic M: Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: Relevance to the diagnosis of neuroblastoma. Pediatr Blood Cancer. 62:587–593. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y and Sobue T: The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Int J Cancer. 140:618–625. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, et al: Reduction in late mortality among 5-Year survivors of childhood cancer. N Engl J Med. 374:833–842. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Huang SY, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, Sznewajs A, DuBois SG, Matthay KK and Seo Y: Patient-specific dosimetry using pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) dynamic PET/CT imaging before [131I]mIBG targeted radionuclide therapy for neuroblastoma. Mol Imaging Biol. 17:284–294. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Kong G, Hofman MS, Murray WK, Wilson S, Wood P, Downie P, Super L, Hogg A, Eu P and Hicks RJ: Initial experience with gallium-68 DOTA-octreotate PET/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma. J Pediatr Hematol Oncol. 38:87–96. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Louis CU and Shohet JM: Neuroblastoma: Molecular pathogenesis and therapy. Annu Rev Med. 66:49–63. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer K, Roberts SS, Basu EM, Yataghene K and Cheung N-KV: Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget. 7:4155–4166. 2016. View Article : Google Scholar : PubMed/NCBI

11 

de Oliveira MR, Schuck PF and Bosco SMD: Tanshinone I induces mitochondrial protection through an Nrf2-dependent mechanism in paraquat-treated human neuroblastoma SH-SY5Y cells. Mol Neurobiol. 54:4597–4608. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Almeida VR, Vieira IA, Buendia M, Brunetto AT, Gregianin LJ, Brunetto AL, Klamt F, de Farias CB, Abujamra AL, Lopez PLDC, et al: Combined treatments with a retinoid receptor agonist and epigenetic modulators in human neuroblastoma cells. Mol Neurobiol. 54:7610–7619. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Radogna F, Cerella C, Gaigneaux A, Christov C, Dicato M and Diederich M: Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma. Oncogene. 35:3839–3853. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Krytska K, Ryles HT, Sano R, Raman P, Infarinato NR, Hansel TD, Makena MR, Song MM, Reynolds CP and Mossé YP: Crizotinib synergizes with chemotherapy in preclinical models of neuroblastoma. Clin Cancer Res. 22:948–960. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Esposito MR, Aveic S, Seydel A and Tonini GP: Neuroblastoma treatment in the post-genomic era. J Biomed Sci. 24:142017. View Article : Google Scholar : PubMed/NCBI

16 

Young K, Alusi G and Korbonits M: Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma. Endoc Abstr. 38:1532015.

17 

Lattanzio F, Carboni L, Carretta D, Candeletti S and Romualdi P: Treatment with the neurotoxic Aβ (25–35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells. Exp Toxicol Pathol. 68:271–276. 2016. View Article : Google Scholar : PubMed/NCBI

18 

George SL, Falzone N, Chittenden S, Kirk SJ, Lancaster D, Vaidya SJ, Mandeville H, Saran F, Pearson AD, Du Y, et al: Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma. Nucl Med Commun. 37:466–472. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Bagatell R and Cohn SL: Genetic discoveries and treatment advances in neuroblastoma. Curr Opin Pediatr. 28:19–25. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Soriano A, París-Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, Bray I, Vidal I, Almazán-Moga A, Molist C, et al: MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget. 7:9271–9287. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2018
Volume 16 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Li C, Xu C, Hao X, Yu X and Li Q: Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children. Oncol Lett 16: 2439-2443, 2018
APA
Zhang, X., Li, C., Xu, C., Hao, X., Yu, X., & Li, Q. (2018). Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children. Oncology Letters, 16, 2439-2443. https://doi.org/10.3892/ol.2018.8959
MLA
Zhang, X., Li, C., Xu, C., Hao, X., Yu, X., Li, Q."Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children". Oncology Letters 16.2 (2018): 2439-2443.
Chicago
Zhang, X., Li, C., Xu, C., Hao, X., Yu, X., Li, Q."Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in children". Oncology Letters 16, no. 2 (2018): 2439-2443. https://doi.org/10.3892/ol.2018.8959